These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 17200173)

  • 1. Functional single-nucleotide polymorphisms in the secretogranin III (SCG3) gene that form secretory granules with appetite-related neuropeptides are associated with obesity.
    Tanabe A; Yanagiya T; Iida A; Saito S; Sekine A; Takahashi A; Nakamura T; Tsunoda T; Kamohara S; Nakata Y; Kotani K; Komatsu R; Itoh N; Mineo I; Wada J; Funahashi T; Miyazaki S; Tokunaga K; Hamaguchi K; Shimada T; Tanaka K; Yamada K; Hanafusa T; Oikawa S; Yoshimatsu H; Sakata T; Matsuzawa Y; Kamatani N; Nakamura Y; Hotta K
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1145-54. PubMed ID: 17200173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretogranin II binds to secretogranin III and forms secretory granules with orexin, neuropeptide Y, and POMC.
    Hotta K; Hosaka M; Tanabe A; Takeuchi T
    J Endocrinol; 2009 Jul; 202(1):111-21. PubMed ID: 19357184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of single-nucleotide polymorphisms in MTMR9 gene with obesity.
    Yanagiya T; Tanabe A; Iida A; Saito S; Sekine A; Takahashi A; Tsunoda T; Kamohara S; Nakata Y; Kotani K; Komatsu R; Itoh N; Mineo I; Wada J; Masuzaki H; Yoneda M; Nakajima A; Miyazaki S; Tokunaga K; Kawamoto M; Funahashi T; Hamaguchi K; Tanaka K; Yamada K; Hanafusa T; Oikawa S; Yoshimatsu H; Nakao K; Sakata T; Matsuzawa Y; Kamatani N; Nakamura Y; Hotta K
    Hum Mol Genet; 2007 Dec; 16(24):3017-26. PubMed ID: 17855449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of variations in the FTO, SCG3 and MTMR9 genes with metabolic syndrome in a Japanese population.
    Hotta K; Kitamoto T; Kitamoto A; Mizusawa S; Matsuo T; Nakata Y; Kamohara S; Miyatake N; Kotani K; Komatsu R; Itoh N; Mineo I; Wada J; Yoneda M; Nakajima A; Funahashi T; Miyazaki S; Tokunaga K; Masuzaki H; Ueno T; Hamaguchi K; Tanaka K; Yamada K; Hanafusa T; Oikawa S; Yoshimatsu H; Sakata T; Matsuzawa Y; Nakao K; Sekine A
    J Hum Genet; 2011 Sep; 56(9):647-51. PubMed ID: 21796137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems.
    Broberger C; De Lecea L; Sutcliffe JG; Hökfelt T
    J Comp Neurol; 1998 Dec; 402(4):460-74. PubMed ID: 9862321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New insights about obesity-related genes].
    Hotta K
    Nihon Rinsho; 2009 Feb; 67(2):253-6. PubMed ID: 19202896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretogranin III may be an indicator of paraquat-induced astrocyte activation and affects the recruitment of BDNF during this process.
    Zhan X; Li F; Chu Q; Pang H
    Int J Mol Med; 2018 Dec; 42(6):3622-3630. PubMed ID: 30280190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common neuropeptide Y2 receptor gene variant is protective against obesity among Swedish men.
    Lavebratt C; Alpman A; Persson B; Arner P; Hoffstedt J
    Int J Obes (Lond); 2006 Mar; 30(3):453-9. PubMed ID: 16331299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between Leptin gene polymorphisms and plasma leptin level in three consanguineous families with obesity.
    Fourati M; Mnif M; Kharrat N; Charfi N; Kammoun M; Fendri N; Sessi S; Abid M; Rebai A; Fakhfakh F
    Gene; 2013 Sep; 527(1):75-81. PubMed ID: 23751306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of 336 single-nucleotide polymorphisms in 85 obesity-related genes revealed McKusick-Kaufman syndrome gene variants are associated with metabolic syndrome.
    Hotta K; Nakamura T; Takasaki J; Takahashi H; Takahashi A; Nakata Y; Kamohara S; Kotani K; Komatsu R; Itoh N; Mineo I; Wada J; Masuzaki H; Yoneda M; Nakajima A; Funahashi T; Miyazaki S; Tokunaga K; Hamaguchi K; Tanaka K; Yamada K; Hanafusa T; Oikawa S; Yoshimatsu H; Nakao K; Sakata T; Matsuzawa Y; Kamatani N; Nakamura Y
    J Hum Genet; 2009 Apr; 54(4):230-5. PubMed ID: 19247371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single nucleotide polymorphisms in the mitochondrial control region are associated with metabolic phenotypes and oxidative stress.
    Weng SW; Lin TK; Wang PW; Chen SD; Chuang YC; Liou CW
    Gene; 2013 Dec; 531(2):370-6. PubMed ID: 23954872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive association of obesity with single nucleotide polymorphisms of syndecan 3 in the Korean population.
    Ha E; Kim MJ; Choi BK; Rho JJ; Oh DJ; Rho TH; Kim KH; Lee HJ; Shin DH; Yim SV; Baik HH; Chung JH; Kim JW
    J Clin Endocrinol Metab; 2006 Dec; 91(12):5095-9. PubMed ID: 17018662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms of the HCR gene and a genomic segment in close proximity to HLA-C are associated with patients with psoriasis in Taiwan.
    Chang YT; Shiao YM; Chin PJ; Liu YL; Chou FC; Wu S; Lin YF; Li LH; Lin MW; Liu HN; Tsai SF
    Br J Dermatol; 2004 Jun; 150(6):1104-11. PubMed ID: 15214895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulated expression of secretogranin III is involved in neurotoxin-induced dopaminergic neuron apoptosis.
    Li F; Tian X; Zhou Y; Zhu L; Wang B; Ding M; Pang H
    J Neurosci Res; 2012 Dec; 90(12):2237-46. PubMed ID: 22987761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic characterization of secretory granules in dopaminergic neurons indicates chromogranin/secretogranin-mediated protein processing impairment in Parkinson's disease.
    Wen G; Pang H; Wu X; Jiang E; Zhang X; Zhan X
    Aging (Albany NY); 2021 Aug; 13(16):20335-20358. PubMed ID: 34420933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretogranin III: a diabetic retinopathy-selective angiogenic factor.
    Li W; Webster KA; LeBlanc ME; Tian H
    Cell Mol Life Sci; 2018 Feb; 75(4):635-647. PubMed ID: 28856381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic linkage and association of the growth hormone secretagogue receptor (ghrelin receptor) gene in human obesity.
    Baessler A; Hasinoff MJ; Fischer M; Reinhard W; Sonnenberg GE; Olivier M; Erdmann J; Schunkert H; Doering A; Jacob HJ; Comuzzie AG; Kissebah AH; Kwitek AE
    Diabetes; 2005 Jan; 54(1):259-67. PubMed ID: 15616037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation analysis of the MCHR1 gene in human obesity.
    Wermter AK; Reichwald K; Büch T; Geller F; Platzer C; Huse K; Hess C; Remschmidt H; Gudermann T; Preibisch G; Siegfried W; Goldschmidt HP; Li WD; Price RA; Biebermann H; Krude H; Vollmert C; Wichmann HE; Illig T; Sørensen TI; Astrup A; Larsen LH; Pedersen O; Eberlé D; Clément K; Blundell J; Wabitsch M; Schäfer H; Platzer M; Hinney A; Hebebrand J
    Eur J Endocrinol; 2005 Jun; 152(6):851-62. PubMed ID: 15941924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Secretogranin III Concentrations Were Increased in Subjects with Metabolic Syndrome and Independently Associated with Fasting Plasma Glucose Levels.
    Lin CC; Cheng KP; Hung HC; Li CH; Lin CH; Chang CJ; Hu CY; Wu HT; Ou HY
    J Clin Med; 2019 Sep; 8(9):. PubMed ID: 31514320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variation in the visfatin gene (PBEF1) and its relation to glucose metabolism and fat-depot-specific messenger ribonucleic acid expression in humans.
    Böttcher Y; Teupser D; Enigk B; Berndt J; Klöting N; Schön MR; Thiery J; Blüher M; Stumvoll M; Kovacs P
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2725-31. PubMed ID: 16636125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.